Yuki Kageyama to Trans-Activators
This is a "connection" page, showing publications Yuki Kageyama has written about Trans-Activators.
Connection Strength
0.271
-
Prognostic significance of endothelial Per-Arnt-sim domain protein 1/hypoxia-inducible factor-2alpha expression in a subset of tumor associated macrophages in invasive bladder cancer. J Urol. 2004 Mar; 171(3):1080-4.
Score: 0.042
-
Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res. 2003 Nov 15; 9(15):5501-7.
Score: 0.041
-
Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms. Br J Cancer. 2003 Mar 10; 88(5):740-7.
Score: 0.040
-
p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation. Exp Cell Res. 2002 Jun 10; 276(2):194-200.
Score: 0.038
-
Positive expression of HIF-2alpha/EPAS1 in invasive bladder cancer. Urology. 2002 May; 59(5):774-8.
Score: 0.037
-
Regulation of vascular endothelial growth factor transcription by endothelial PAS domain protein 1 (EPAS1) and possible involvement of EPAS1 in the angiogenesis of renal cell carcinoma. Cancer. 2001 Apr 15; 91(8):1429-36.
Score: 0.035
-
Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells. Mol Cell Biol. 1998 Mar; 18(3):1172-80.
Score: 0.028
-
Expression failure of the notch signaling system is associated with the pathogenesis of testicular germ cell tumor. Tumour Biol. 2004 May-Jun; 25(3):99-105.
Score: 0.011